C. Baigent, A. Keech, P. Kearney, L. Blackwell, G. Buck et al., Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, issue.9493, pp.3661267-1278, 2005.

P. Sever, B. Dahlof, N. Poulter, H. Wedel, G. Beevers et al., Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA), Drugs, vol.64, issue.Supplement 2, pp.3611149-1158, 2003.
DOI : 10.2165/00003495-200464002-00005

J. Shepherd, G. Blauw, M. Murphy, E. Bollen, B. Buckley et al., Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial, The Lancet, vol.360, issue.9346, pp.3601623-1630, 2002.
DOI : 10.1016/S0140-6736(02)11600-X

J. Shepherd, S. Cobbe, I. Ford, C. Isles, A. Lorimer et al., Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia, N Engl J Med, issue.20, pp.3331301-1307, 1995.

F. Sacks, M. Pfeffer, L. Moye, J. Rouleau, J. Rutherford et al., The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators, N Engl J Med, issue.14, pp.3351001-1009, 1996.

J. Downs, M. Clearfield, S. Weis, E. Whitney, D. Shapiro et al., Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels, JAMA, vol.279, issue.20, pp.2791615-1622, 1998.
DOI : 10.1001/jama.279.20.1615

H. Colhoun, D. Betteridge, P. Durrington, G. Hitman, H. Neil et al., Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial, Lancet, issue.9435, pp.364685-696, 2004.

M. Heart, Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial, Lancet, vol.360, issue.9326, pp.7-22, 2002.

P. Serruys, P. De-feyter, C. Macaya, N. Kokott, J. Puel et al., Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial, Jama, issue.24, pp.2873215-3222, 2002.

L. Wei, S. Ebrahim, P. Bartlett, P. Davey, F. Sullivan et al., Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials, BMJ, vol.330, issue.7495, p.330821, 2005.
DOI : 10.1136/bmj.38398.408032.8F

N. Wieringa, D. Graeff, P. Van-der-werf, G. Vos, and R. , Cardiovascular drugs: discrepancies in demographics between pre- and post-registration use, European Journal of Clinical Pharmacology, vol.55, issue.7
DOI : 10.1007/s002280050670

K. Martin, B. Begaud, P. Latry, G. Miremont-salame, A. Fourrier et al., Differences between clinical trials and postmarketing use, British Journal of Clinical Pharmacology, vol.50, issue.Suppl, pp.86-92, 2004.
DOI : 10.1046/j.1365-2125.2003.01953.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884419

I. Abraha, A. Montedori, F. Stracci, M. Rossi, and C. Romagnoli, Statin compliance in the Umbrian population, European Journal of Clinical Pharmacology, vol.59, issue.8-9, pp.8-9659, 2003.
DOI : 10.1007/s00228-003-0675-2

J. Avorn, J. Monette, A. Lacour, R. Bohn, M. Monane et al., Persistence of Use of Lipid-Lowering Medications, JAMA, vol.279, issue.18, pp.2791458-1462, 1998.
DOI : 10.1001/jama.279.18.1458

J. Benner, R. Glynn, H. Mogun, P. Neumann, M. Weinstein et al., Long-term Persistence in Use of Statin Therapy in Elderly Patients, JAMA, vol.288, issue.4, pp.455-461, 2002.
DOI : 10.1001/jama.288.4.455

H. Caspard, A. Chan, and A. Walker, Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia, Clin Ther, issue.10, pp.271639-1646, 2005.

P. Deambrosis, C. Saramin, G. Terrazzani, L. Scaldaferri, P. Debetto et al., Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994???2003, European Journal of Clinical Pharmacology, vol.23, issue.2, pp.197-203, 2007.
DOI : 10.1007/s00228-006-0239-3

L. Donnelly, A. Doney, A. Morris, C. Palmer, and P. Donnan, Long-term adherence to statin treatment in diabetes, Diabetic Medicine, vol.87, issue.7, pp.850-855, 2008.
DOI : 10.1111/j.1464-5491.2008.02476.x

R. Grant, O. Leary, K. Weilburg, J. Singer, D. Meigs et al., Impact of Concurrent Medication Use on Statin Adherence and Refill Persistence, Archives of Internal Medicine, vol.164, issue.21, pp.2343-2348, 2004.
DOI : 10.1001/archinte.164.21.2343

S. Perreault, L. Blais, D. Lamarre, A. Dragomir, D. Berbiche et al., Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention, British Journal of Clinical Pharmacology, vol.288, issue.5, pp.59564-573, 2005.
DOI : 10.1001/jama.288.14.1775

E. Poluzzi, P. Strahinja, M. Lanzoni, A. Vargiu, M. Silvani et al., Adherence to statin therapy and patients??? cardiovascular risk: a pharmacoepidemiological study in Italy, European Journal of Clinical Pharmacology, vol.63, issue.4, pp.425-432, 2008.
DOI : 10.1007/s00228-007-0428-8

J. Steiner and E. Gardner, Assessing medication adherence from pharmacy records, Pharmacoepidemiology and Drug Safety, vol.27, issue.8, pp.575-577, 2006.
DOI : 10.1002/pds.1259

S. Andrade, K. Kahler, F. Frech, and K. Chan, Methods for evaluation of medication adherence and persistence using automated databases, Pharmacoepidemiology and Drug Safety, vol.9, issue.8, pp.565-574, 2006.
DOI : 10.1002/pds.1230

M. Hudson, E. Rahme, H. Richard, and L. Pilote, Comparison of measures of medication persistency using a prescription drug database, American Heart Journal, vol.153, issue.1, pp.59-65, 2007.
DOI : 10.1016/j.ahj.2006.10.018

J. Steiner, T. Koepsell, S. Fihn, and T. Inui, A General Method of Compliance Assessment Using Centralized Pharmacy Records, Medical Care, vol.26, issue.8, pp.814-823, 1988.
DOI : 10.1097/00005650-198808000-00007

J. Steiner and A. Prochazka, The assessment of refill compliance using pharmacy records: Methods, validity, and applications, Journal of Clinical Epidemiology, vol.50, issue.1, pp.105-116, 1997.
DOI : 10.1016/S0895-4356(96)00268-5

R. Grymonpre, M. Cheang, M. Fraser, C. Metge, and D. Sitar, Validity of a Prescription Claims Database to Estimate Medication Adherence in Older Persons, Medical Care, vol.44, issue.5, pp.471-477, 2006.
DOI : 10.1097/01.mlr.0000207817.32496.cb

L. Hess, M. Raebel, D. Conner, and D. Malone, Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures, Annals of Pharmacotherapy, vol.38, issue.3, pp.1280-1288, 2006.
DOI : 10.1345/aph.1H018

C. Bourgault, M. Sénécal, M. Brisson, M. Marentette, and J. Grégoire, Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study, Journal of Human Hypertension, vol.37, issue.8, pp.607-613, 2005.
DOI : 10.1038/sj.jhh.1001873

M. Becker and L. Maiman, Sociobehavioral Determinants of Compliance with Health and Medical Care Recommendations, Medical Care, vol.13, issue.1, pp.10-24, 1975.
DOI : 10.1097/00005650-197501000-00002

C. Jackevicius, M. Mamdani, and J. Tu, Adherence with statin therapy in elderly patients with and without acute coronary syndromes, ACC Current Journal Review, vol.11, issue.6, pp.462-467, 2002.
DOI : 10.1016/S1062-1458(02)00915-7

B. Stephenson, B. Rowe, R. Haynes, W. Macharia, and G. Leon, The rational clinical examination. Is this patient taking the treatment as prescribed? Jama, pp.2779-2781, 1993.

V. Catalan and J. Lelorier, Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population, Value in Health, vol.3, issue.6, pp.417-426, 2000.
DOI : 10.1046/j.1524-4733.2000.36006.x

F. Penning-van-beest, F. Termorshuizen, W. Goettsch, O. Klungel, J. Kastelein et al., Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study, European Heart Journal, vol.28, issue.2, pp.154-159, 2007.
DOI : 10.1093/eurheartj/ehl391

A. Mantel-teeuwisse, W. Goettsch, O. Klungel, A. De-boer, and R. Herings, Long term persistence with statin treatment in daily medical practice, Heart, vol.90, issue.9, pp.1065-1066, 2004.
DOI : 10.1136/hrt.2003.026187

J. Lachaine, S. Rinfret, E. Merikle, and J. Tarride, Persistence and adherence to cholesterol lowering agents: Evidence from R??gie de l'Assurance Maladie du Qu??bec data, American Heart Journal, vol.152, issue.1, pp.164-169, 2006.
DOI : 10.1016/j.ahj.2005.09.010

G. Gislason, J. Rasmussen, S. Abildstrom, T. Schramm, M. Hansen et al., Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes, Circulation, vol.116, issue.7, pp.116737-744, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.669101

B. Mcginnis, K. Olson, D. Magid, E. Bayliss, E. Korner et al., Factors Related to Adherence to Statin Therapy, Annals of Pharmacotherapy, vol.41, issue.11, pp.411805-1811, 2007.
DOI : 10.1345/aph.1K209

J. Evans and T. Macdonald, Record-linkage for pharmacovigilance in Scotland, British Journal of Clinical Pharmacology, vol.31, issue.1, pp.105-110, 1999.
DOI : 10.1046/j.1365-2125.1999.00853.x

J. Curtis, J. Xi, A. Westfall, H. Cheng, K. Lyles et al., Improving the Prediction of Medication Compliance, Medical Care, vol.47, issue.3, pp.47334-341, 2009.
DOI : 10.1097/MLR.0b013e31818afa1c